Mulmit

Phio Pharmaceuticals Corp.Phio Pharmaceuticals Corp.

PHIO Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2020-12-310-8,793,000-8,794,000
2019-12-3121,000-8,987,000-8,908,000
2018-12-31138,000-7,364,000-7,360,000
2017-12-3115,000-14,062,000-12,452,000
2016-12-3119,000-9,015,000-8,994,000

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-19Plott Ronald Todd15,000
2026-08-18Bitterman Robert JChairman, Pres. & CEO10,000
2026-06-26Bitterman Robert JChairman, Pres. & CEO10,000
2026-02-05Lockshin Curtis16,600
2026-02-05Freeman Jonathan E16,600
2026-02-05Deming David H23,800
2026-02-05Carson Lisa CabottChief Financial Officer47,000
2026-02-05BRADFORD PATRICIA A18,500
2026-02-05Bitterman Robert JChairman, Pres. & CEO120,000
2025-12-31Bitterman Robert JChairman, Pres. & CEO5,000
2025-12-23Bitterman Robert JChairman, Pres. & CEO5,000
2025-11-21Bitterman Robert JChairman, Pres. & CEO5,000

8-K events

FiledItems
2026-08-06Results of operations · Financial statements and exhibits
2026-07-21Officer or director change · Other events · Financial statements and exhibits
2026-05-07Results of operations · Financial statements and exhibits
2026-04-08Entry into a material agreement · Financial statements and exhibits
2026-03-30Other events
2026-03-05Results of operations · Financial statements and exhibits
2026-02-18Officer or director change
2026-02-10Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…